We are live on
!
Find out more
DGI
Discovery Group I Portfolio holdings
AUM
$262M
1-Year Est. Return
29.24%
This Fund
S&P 500
This Quarter
Est. Return
+10.2%
1 Year Est. Return
+29.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$262M
AUM Growth
-$84.2M
(-24%)
Cap. Flow
-$104M
Cap. Flow
% of AUM
-39.79%
Top 10 Holdings %
Top 10 Hldgs %
99.06%
Holding
19
New
2
Increased
5
Reduced
5
Closed
7
Top Buys
| 1 |
BETR
Amplify Snack Brands, Inc.
BETR
|
+$11.8M |
| 2 |
BNFT
Benefitfocus, Inc.
BNFT
|
+$10.5M |
| 3 |
IVTY
Invuity, Inc
IVTY
|
+$9.5M |
| 4 |
PLPM
Planet Payment, Inc
PLPM
|
+$3.95M |
| 5 |
BCOV
Brightcove, Inc.
BCOV
|
+$1.67M |
Top Sells
| 1 |
PMC
PharMerica Corporation
PMC
|
+$33M |
| 2 |
WBMD
WebMD Health Corp.
WBMD
|
+$21.4M |
| 3 |
EPAY
Bottomline Technologies Inc
EPAY
|
+$19.7M |
| 4 |
ASRT
Assertio
ASRT
|
+$17.8M |
| 5 |
LivePerson
LPSN
|
+$17.2M |
Sector Composition
| 1 | Healthcare | 32.11% |
| 2 | Technology | 25.56% |
| 3 | Consumer Staples | 13.31% |
| 4 | Communication Services | 11.59% |
| 5 | Industrials | 7.81% |
Similar funds
FC
GIIO
UBWV
SC
EM
SIMC
BSWMG
PCMI
Discovery Group I's Q3 2017 Portfolio in Review
As of Q3 2017, Discovery Group I held 19 positions worth $262M, down 24% from $346M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Discovery Group I withdrew a net $104M in Q3 2017, closing 7 positions and reducing 5 holdings. Its most notable exit was PharMerica Corporation, an estimated $33M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Discovery Group I opened a new position in Brightcove, Inc. worth $1.76M.
- Discovery Group I's largest Q3 2017 buy was Brightcove, Inc.: 244,923 shares worth $1.76M.
- Discovery Group I added most to Amplify Snack Brands, Inc. in Q3 2017, an estimated $11.8M increase.
- Discovery Group I's biggest Q3 2017 reduction was LivePerson, cutting an estimated $17.2M.
- Discovery Group I fully exited PharMerica Corporation in Q3 2017, selling an estimated $33M.
- Discovery Group I's ten largest holdings make up 99% of its $262M portfolio in Q3 2017.
- Discovery Group I opened 2 new positions and closed 7 in Q3 2017.
- Discovery Group I's portfolio value fell 24% quarter-over-quarter to $262M.
Based on Discovery Group I's 13F filing for Q3 2017, filed 13 Nov 2017.